Cannabis smoking linked to oral bacteria that caused brain changes in mice

Chronic cannabis smokers harbored elevated levels of the oral bacterium Actinomyces meyeri, which when fed to mice for six months decreased activity, increased brain macrophage infiltration, and boosted amyloid-beta production.

Luo, Zhenwu et al.·EBioMedicine·2021·Preliminary EvidenceObservational
RTHC-03303ObservationalPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Cannabis smokers showed oral microbial dysbiosis with increased Streptococcus and Actinomyces and decreased Neisseria. Mice orally exposed to the cannabis-enriched bacterium Actinomyces meyeri for six months showed decreased global activity, increased macrophage brain infiltration, and increased beta-amyloid 42 protein production.

Key Numbers

16 cannabis smokers vs 27 controls; mice inoculated twice weekly for 6 months; Actinomyces meyeri enrichment inversely associated with age of first cannabis use; increased beta-amyloid 42 production in mouse brains

How They Did This

Researchers compared saliva microbiomes of 16 chronic cannabis smokers with cannabis use disorder and 27 non-smoking controls using 16S rRNA sequencing. Then mice were orally inoculated with Actinomyces meyeri, Actinomyces odontolyticus, or Neisseria elongata twice weekly for six months to test functional effects.

Why This Research Matters

This is the first study to connect cannabis-associated changes in oral bacteria to potential neurological consequences, suggesting a novel pathway by which chronic cannabis smoking might affect brain health.

The Bigger Picture

The oral microbiome-brain axis is an emerging area of research. This study adds cannabis smoking as a factor that may reshape oral bacteria in ways that have downstream neurological consequences, though the pathway from human observation to mouse experiment needs further validation.

What This Study Doesn't Tell Us

Very small human sample (16 vs 27). Mouse model may not replicate human oral-brain pathways. Cannot determine whether cannabis itself or combustion byproducts caused the microbial changes. No control for tobacco co-use.

Questions This Raises

  • ?Do non-smoked forms of cannabis produce the same oral microbial changes?
  • ?Is this pathway relevant to human neurodegenerative disease risk?
  • ?Could oral hygiene interventions mitigate these effects in cannabis smokers?

Trust & Context

Key Stat:
First study linking cannabis-associated oral bacteria to brain amyloid-beta production
Evidence Grade:
Novel translational study combining human microbiome data with animal experiments, but very small human sample and animal-to-human extrapolation limits conclusions.
Study Age:
Published in 2021.
Original Title:
Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases β-amyloid protein production in the brain.
Published In:
EBioMedicine, 74, 103701 (2021)
Database ID:
RTHC-03303

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Does this mean cannabis causes Alzheimer's?

No. This study found a specific oral bacterium enriched in cannabis smokers that increased amyloid-beta in mice. Whether this translates to Alzheimer's risk in humans is unknown and would require much more research.

Was it the cannabis or the smoking?

The study cannot distinguish between effects of cannabis compounds and effects of smoke inhalation on oral bacteria. Non-smoked cannabis was not tested.

Read More on RethinkTHC

Cite This Study

RTHC-03303·https://rethinkthc.com/research/RTHC-03303

APA

Luo, Zhenwu; Fitting, Sylvia; Robinson, Catrina; Benitez, Andreana; Li, Min; Wu, Yongxia; Fu, Xiaoyu; Amato, Davide; Ning, Wangbin; Funderburg, Nicholas; Wang, Xu; Zhou, Zejun; Yu, Xuezhong; Wagner, Amanda; Cong, Xiaomei; Xu, Wanli; Maas, Kendra; Wolf, Bethany J; Huang, Lei; Yu, Jeremy; Scott, Alison; Mcrae-Clark, Aimee; Hamlett, Eric D; Jiang, Wei. (2021). Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases β-amyloid protein production in the brain.. EBioMedicine, 74, 103701. https://doi.org/10.1016/j.ebiom.2021.103701

MLA

Luo, Zhenwu, et al. "Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases β-amyloid protein production in the brain.." EBioMedicine, 2021. https://doi.org/10.1016/j.ebiom.2021.103701

RethinkTHC

RethinkTHC Research Database. "Chronic cannabis smoking-enriched oral pathobiont drives beh..." RTHC-03303. Retrieved from https://rethinkthc.com/research/luo-2021-chronic-cannabis-smokingenriched-oral

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.